N Hama, R Abe, A Gibson, EJ Phillips - The Journal of Allergy and Clinical …, 2022 - Elsevier
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS) is one example of a severe delayed T-cell–mediated adverse …
BR Del Pozzo‐Magaña… - British Journal of Clinical …, 2022 - Wiley Online Library
Drug‐induced skin disease or cutaneous adverse drug reactions (CADRs) are terms that encompass the clinical manifestations of the skin, mucosae and adnexa induced by a drug …
C Mabilat, MF Gros, A Van Belkum… - JAC-Antimicrobial …, 2022 - academic.oup.com
Penicillin allergy, the most frequently reported drug allergy, has been associated with suboptimal antibiotic therapy, increased antimicrobial resistance, increased rates of …
DR Germolec, H Lebrec, SE Anderson… - Environmental …, 2022 - ehp.niehs.nih.gov
Background: Key characteristics (KCs), properties of agents or exposures that confer potential hazard, have been developed for carcinogens and other toxicant classes. KCs …
Drug-induced delayed hypersensitivity reactions (DHRs) is still a clinical and healthcare burden in every country. Increasing reports of DHRs have caught our attention to explore the …
Despite the significant negative impact drug allergies can have on patient care, the diagnosis is largely based on clinical history, and there are limited diagnostic tests that can …
ME Marks, RK Botta, R Abe, TM Beachkofsky… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Abstract Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) is a predominantly drug-induced disease, with a mortality rate of 15–20%, that engages the …
S Matsuzaki, H Kamiya, I Inoshima, Y Hirasawa… - Internal …, 2022 - jstage.jst.go.jp
A 65-year-old man experienced cough and shortness of breath 3 days after receiving the first dose of the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine. Chest X-ray …
Delayed drug T-cell immune-mediated hypersensitivity reactions have a large clinical heterogeneity varying from mild maculopapular exanthema (MPE) to severe cutaneous …